Lumos Diagnostics is expanding its global footprint after agreeing an ongoing manufacturing deal for a customized lateral flow reader with a California-based partner.
Lumos worked with the life sciences company to customize the Leelu Reader’s optics to suit their assay chemistry and lateral flow test strips. The reader’s software was also modified to accommodate their algorithms and provide a tailored output of data to meet the needs of end users.
Lumos CEO Dr Sacha Dopheide said: “2018 is shaping up to be a big year for Lumos as we take on new partners, new contracts, and move to larger new premises in Carlsbad, California.
“The Leelu Reader is just the first in a pipeline of reader platforms being developed with global partners, including two international pharmaceutical companies.”
A subsidiary of Planet Innovation Group, Lumos develops and manufactures custom rapid point-of-care (POC) diagnostic solutions. In 2017, Lumos acquired assay development company Kestrel BioSciences, becoming the only integrated provider of custom POC assays and readers. In addition to reader and assay development, Lumos also has in-house expertise in cloud and data management, and manufacturing.
Find out more about Lumos Diagnostics
Suraya is the Marketing Communications Manager at Planet Innovation. A former journalist, Suraya is passionate about telling engaging stories for companies that have a positive impact on the world.
A roundup of the latest news and opinions from PI.
Lumos Diagnostics develops custom products for its partners using a unique combination of integrated assay and engineering capability paired with its proven reader optical technologies.
PI has opened a new Northern Wing of their Advanced Manufacturing Center in Box Hill, to accommodate an increasing number of local and international manufacturing contracts.
When designers work with manufacturing experts from the start, their clients are the winners. Why? Costs fall, profits grow and products have a better chance of success.
Pharmaceutical giant Merck Serono has signed an exclusive deal securing global marketing and commercialization rights to Genea Biomedx’s range of IVF products including Gavi and Geri, which were designed by Genea with development partner, Planet Innovation.
News
Lumos Diagnostics develops custom products for its partners using a unique combination of integrated assay and engineering capability paired with its proven reader optical technologies.
Diagnostics
Life Sciences
Medical Devices
Internet of Things